Navigation Links
Dendreon Announces Closing of Common Stock Offering
Date:5/13/2009

d be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.

This news release contains forward-looking statements that are subject to risks and uncertainties. These statements include Dendreon's anticipated use of proceeds. Factors that could affect these forward-looking statements include, but are not limited to, developments affecting Dendreon's business and prospects, including the progress on the commercialization efforts for PROVENGE and requisite receipt of FDA licensure for marketing and the risk that additional capital could be needed in the future for the potential commercialization of PROVENGE. Information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission and the prospectus supplement relating to the offering, which are available at www.sec.gov. Dendreon cautions investors not to place undue reliance on the forward-looking
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
9. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015  Natera, Inc. (Nasdaq: NTRA ), a ... circulating cell-free DNA, today announced that it will release ... after the market close on August 12, 2015. Natera ... p.m. PT (4:30 p.m. ET) to discuss its financial ... Results Conference Call  Date: , Wednesday, August 12, 2015  ...
(Date:8/4/2015)... 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ), ... China , today announced that it will release ... June 30, 2015, after market close on Wednesday, August ... Thursday, August 13, 2015, at 8:00 a.m. EDT (Thursday, ... to review the Company,s financial results and provide an ...
(Date:8/3/2015)... LONDON , August 3, 2015 ... Portland Hospital waved the shortfall of ... fanatic could stand normally for the first time. ...      (Photo: http://photos.prnewswire.com/prnh/20150803/254229 ) The ... Jude,s legs allowing him to carry out his wish ...
(Date:8/3/2015)... WESTWOOD, Mass. , Aug. 3, 2015  Merck ... company for innovative and top-quality high-tech products in the ... together with the US-based company Nano-C, their development and ... field of organic photovoltaics (OPV). Merck KGaA, Darmstadt, ... participate in the growing OPV sector. Novel ...
Breaking Biology Technology:Natera to Release Second Quarter 2015 Results on August 12, 2015 2Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4
... I am familiar with bad jobs. , ,My youngest brother ... involved wandering through unfamiliar neighborhoods, worrying about making a daily ... a shared apartment. After a few weeks of this, my ... brother once found a job selling environmentally friendly household products, ...
... the seed capital he needs to fuel his rapidly growing ... are legally allowed to make angel investments. , ,This is ... Wisconsins tech community, Peter M. Skanavis is doing everything he ... angel investments to actually take the plunge and put their ...
... stories coming out of California, but the failure of flight ... one of the weirdest. , ,The radio system used by ... a snit when its regular monthly maintenance wasnt performed and ... but couldnt talk to them, even as the planes converged ...
Cached Biology Technology:Beware the cold-call job interview 2Beware the cold-call job interview 3Beware the cold-call job interview 4Beware the cold-call job interview 5Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 2Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 3Investor profile: Peter M. Skanavis, tech angel, sees investing as civic duty 4Proactive nightmares 2
(Date:7/9/2015)... DUBLIN , July 07, 2015 ... has announced the addition of the "Biometrics ... and Forecasts 2015-2020" report to their offering. ... a major contributor to this growth and the ... US$5.5 billion in revenue for companies involved in ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... a reason to be glad about madder: The climbing plant has ... Rice University and the City College of New York have discovered ... of purpurin, an organic dye that can be turned into a ... used since ancient times to create dye for fabrics. ...
... Troy, N.Y. A new study from engineering researchers ... how the little-understood protein osteocalcin plays a significant role ... lead to new strategies and therapeutics for fighting osteoporosis ... by the U.S. National Institutes of Health, the study ...
... Asian soybean rust ( Phakopsora pachyrhizi ) pose a ... because they can be blown great distances by the ... to determine whether these spores are viable. "Finding ... and able to infect plants," said USDA Agricultural Research ...
Cached Biology News:Rice cultivates green batteries from plant 2Rice cultivates green batteries from plant 3Battling brittle bones... with broccoli and spinach? 2Dead or alive? A new test to determine viability of soybean rust spores 2
APG5 autophagy 5-like (S. cerevisiae)...
Human Jagged 2 Biotinylated Affinity Purified PAb...
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
Griess Reagent component for determination of nitrite in aqueous solutions....
Biology Products: